Navigation Links
Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
Date:5/28/2008

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the event are as follows:

What: Sequenom: The Future of Noninvasive Prenatal Diagnostics

When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time

Where: http://www.sequenom.com

Agenda:

Hosted by:

Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc.

Presenters:

Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine

Brown University Medical School

"Methods for screening pregnancies for Down syndrome"

Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp

Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY

Downstate Medical Center; Clinical Professor, Albert Einstein College of

Medicine

"Current clinical practice for Down syndrome screening and diagnosis"

Betty Dragon, Ph.D., Senior Vice President, Research & Development of

Sequenom, Inc.

"Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down

syndrome. Technical Achievements, Milestones and Future Challenges"

Dennis Lo, Consultant to Sequenom, Inc.

"The future of prenatal diagnosis: Progress through fetal nucleic acids"

How: Live over the Internet - Simply log on to the web at the address

above. Presentation will be archived.

Contact: Lippert/Heilshorn & Associates

Jody Cain (jcain@lhai.com)

310-691-7100

About Sequenom

Sequenom is committed to providing the best genetic analysis products for research and the molecular diagnostic markets. The Company makes available superior solutions for genomic science in biomedical research, livestock and agricultural applications and molecular medicine, as well as for various diagnostic markets, including noninvasive prenatal testing, oncology and infectious diseases. Sequenom's proprietary MassARRAY(R) system delivers reliable and specific data from complex biological samples and from genetic target materials available only in trace amounts.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to: webcast@multivu.com.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
2. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
3. Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
4. CorVel Corporation Announces Earnings Release Webcast
5. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
6. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
8. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
9. Quest Diagnostics Announces Annual Shareholders Meeting Webcast
10. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
11. Exelixis Announces May 13 Webcast of Presentation at the Bank of America Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... (PRWEB) , ... May 22, 2017 , ... ... year in a row in the Aragon Research Globe™ for Corporate Learning, 2017. ... with industry direction and market demand, and effectively perform against those strategies. NetDimensions’ ...
(Date:5/23/2017)... Philadelphia, PA. (PRWEB) , ... May 23, 2017 ... ... Clinical Works as Vice President of Clinical Operations. She brings years ... Pharmaceuticals, and Yaupon Therapeutics. From her professional foundation as a licensed occupational therapist, ...
(Date:5/22/2017)... MA (PRWEB) , ... May 22, 2017 , ... Stratevi, ... has expanded to the East Coast. It has opened an office in downtown Boston ... therapies are finding it increasingly more important to generate evidence on the value they ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):